Yazılar

Neuralink Plans High-Volume Brain Implant Production by 2026, Musk Says

/in /tarafından

Neuralink will begin “high-volume production” of its brain–computer interface implants and shift to a fully automated surgical procedure in 2026, according to a statement by Elon Musk.

Musk shared the update on the social media platform X on Wednesday. Neuralink did not immediately respond to a request for comment from Reuters.

The Neuralink implant is designed to help people with neurological conditions such as spinal cord injuries by enabling direct communication between the brain and computers. The company’s first patient has demonstrated the ability to play video games, browse the internet, post on social media and control a laptop cursor using only their thoughts.

Neuralink began human trials of its brain implant technology in 2024, after resolving safety concerns raised by the U.S. Food and Drug Administration. The regulator had initially rejected the company’s application in 2022, citing risks related to the device and surgical process.

In September, Neuralink said that 12 people worldwide with severe paralysis had received its implants and were using them to control both digital and physical tools through neural signals. The company has positioned the technology as a potential breakthrough for restoring independence to patients with limited mobility.

The startup has also attracted strong investor interest. In June, Neuralink raised $650 million in a funding round, providing capital to scale manufacturing, expand clinical trials and advance automation plans ahead of its targeted 2026 production push.

Neuralink Expands Human Trials, 12 People Now Using Brain Implants

/in /tarafından

Elon Musk’s Neuralink announced Tuesday that 12 people worldwide have received its brain implants, marking steady progress in its clinical rollout.

Key Details

  • Patient Numbers: Up from 7 in June, when partner Barrow Neurological Institute confirmed its involvement.

  • Usage Stats: Collectively, patients have logged 2,000 days of implant use and over 15,000 hours of activity, using the device to control both digital and physical tools through thought.

  • Trials Abroad: A new clinical study will launch in the UK, partnering with University College London Hospitals and Newcastle Hospitals.

  • Funding: Neuralink raised $650 million in June to support expansion.

Background

  • Neuralink began human trials in 2024 after overcoming U.S. FDA safety objections that initially blocked approval in 2022.

  • The company’s implants are aimed at restoring movement and communication for people with severe paralysis, representing a major step in brain-computer interface (BCI) technology.

Outlook

  • The trials will help Neuralink test long-term safety, reliability, and potential new medical applications.

  • If successful, the technology could pave the way for broader use cases — from medical rehabilitation to advanced human-computer interaction.

Neuralink Advances Feasibility Study with Brain Implant and Robotic Arm

/in /tarafından

Elon Musk’s brain technology company Neuralink announced on Monday its approval to initiate a new feasibility study featuring its brain implant and an experimental robotic arm. This study builds on the company’s PRIME trial, which evaluates the safety of Neuralink’s wireless brain-computer interface and its advanced surgical robot.

The primary objective is to test the implant’s efficacy in helping quadriplegic patients—individuals suffering from complete or partial paralysis—control external devices purely through their thoughts.

Expanding Research Scope

Neuralink plans to include participants from the ongoing PRIME trial in this new feasibility study, as confirmed in a statement on the social media platform X (formerly Twitter). Both the U.S. Food and Drug Administration (FDA) and Neuralink have yet to release further details about this study.

Last week, Neuralink received regulatory approval from Health Canada to initiate trials in the country. Canadian neurosurgeons collaborating with Neuralink aim to recruit six patients with paralysis for the study.

Progress in the United States

In the U.S., Neuralink has already implanted its device in two trial patients. The first patient has successfully used the implant to perform various tasks, including playing video games, browsing the internet, posting on social media, and moving a cursor on their laptop.

The second patient has also reported promising results, using the implant to play video games and learn 3D design techniques. Neuralink has expressed optimism about the device’s ongoing performance in these initial cases.

Innovation in Brain-Computer Interfaces

Neuralink’s work represents a significant step forward in brain-computer interface technology, which holds transformative potential for individuals with severe mobility impairments. The addition of the feasibility study underscores the company’s commitment to refining its technology and expanding its applications.